Ángeles Castro

685 total citations
19 papers, 348 citations indexed

About

Ángeles Castro is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ángeles Castro has authored 19 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Ángeles Castro's work include Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Ángeles Castro is often cited by papers focused on Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Ángeles Castro collaborates with scholars based in Spain, United States and Italy. Ángeles Castro's co-authors include J. Pedreira, Vincent Soriano, Javier García‐Samaniego, Marina Núñez, Juan González, Álvaro Mena, José Ramón Arribas, Pablo Barreiro, Mayte Pérez‐Olmeda and Inmaculada Jiménez-Nàcher and has published in prestigious journals such as PLoS ONE, Scientific Reports and The American Journal of Gastroenterology.

In The Last Decade

Ángeles Castro

19 papers receiving 334 citations

Peers

Ángeles Castro

HEPAT

EPIDE

VIROL

RHEUM

S.F.A. Patruno Italy

José del Valle Spain

Josep M. Guardiola Spain

Francisco Socas Gavilán Spain

Tiziana Tieghi Italy

V Weich Germany

Michèle Martinot France

C. Caudai Italy

Zayani Sims United States

Ana Arizcorreta Spain

S.F.A. Patruno Italy

Ángeles Castro

209 ×0.7

HEPAT

192 ×0.7

EPIDE

72 ×0.7

27 ×0.9

VIROL

41 ×1.5

RHEUM

Citations per year, relative to Ángeles Castro Ángeles Castro (= 1×) peers S.F.A. Patruno

Countries citing papers authored by Ángeles Castro

Since Specialization

Citations

This map shows the geographic impact of Ángeles Castro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángeles Castro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángeles Castro more than expected).

Fields of papers citing papers by Ángeles Castro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángeles Castro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángeles Castro. The network helps show where Ángeles Castro may publish in the future.

Co-authorship network of co-authors of Ángeles Castro

This figure shows the co-authorship network connecting the top 25 collaborators of Ángeles Castro. A scholar is included among the top collaborators of Ángeles Castro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángeles Castro. Ángeles Castro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Castro, Ángeles, et al.. (2022). Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain.. PubMed. 46(6). 327–334. 1 indexed citations

Mena, Álvaro, et al.. (2019). Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy. Scientific Reports. 9(1). 17184–17184. 4 indexed citations

Jiménez‐Sousa, María Ángeles, Javier López Jiménez, Amanda Fernández‐Rodríguez, et al.. (2019). DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study. Journal of Biomedical Science. 26(1). 83–83. 9 indexed citations

Mena, Álvaro, et al.. (2019). Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals. PLoS ONE. 14(6). e0217052–e0217052. 4 indexed citations

Cachay, Edward R., Álvaro Mena, Luís Morano, et al.. (2019). Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus. Open Forum Infectious Diseases. 6(3). ofz070–ofz070. 23 indexed citations

Mena, Álvaro, et al.. (2018). Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapy. HIV Clinical Trials. 19(5). 197–201. 3 indexed citations

Morano, Luís, Ángeles Castro, Marta Suárez, et al.. (2017). Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients. Journal of Clinical Virology. 88. 58–61. 22 indexed citations

Casado, José L., Álvaro Mena, Sara Bañón, et al.. (2014). Efficacy and safety of etravirine‐containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosis. Journal of the International AIDS Society. 17(4S3). 19574–19574. 4 indexed citations

Everson, Gregory T., Samuel Lee, Stefan Zeuzem, et al.. (2014). Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With Cirrhosis After Treatment With ABT-450/R/Ombitasvir, Dasabuvir and Ribavirin. The American Journal of Gastroenterology. 109. S132–S132. 1 indexed citations

10.

Mena, Álvaro, Berta Pernas, Ángeles Castro, et al.. (2013). Neoplasias en pacientes con infección por VIH: Estudio descriptivo de 129 casos en el período 1993-2010. Revista chilena de infectología. 30(2). 156–161. 8 indexed citations

11.

Mena, Álvaro, J. Pedreira, Ángeles Castro, et al.. (2013). Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers. Journal of Gastroenterology and Hepatology. 29(1). 173–178. 32 indexed citations

12.

Lorenzo, José Ignacio Leal, et al.. (2004). Total HCV core antigen assay. Journal of Virological Methods. 120(2). 173–177. 11 indexed citations

13.

Pérez‐Olmeda, Mayte, Marina Núñez, Míriam Romero, et al.. (2003). Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS. 17(7). 1023–1028. 148 indexed citations

14.

Pozo, Jesús del, et al.. (2003). Eyelash length in HIV-infected patients. AIDS. 17(11). 1695–1696. 14 indexed citations

15.

Núñez, Marina, Carmen de Mendoza, E Casas, et al.. (2002). Resistance mutations in HIV-infected patients experiencing early failure with nelfinavir-containing triple combinations.. PubMed. 8(9). CR620–3. 7 indexed citations

16.

Diago, M., Luis García‐Villarreal, Ángeles Castro, et al.. (2001). Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis c. Journal of Medical Virology. 64(4). 460–465. 5 indexed citations

17.

Castro, Ángeles, Luis Inglada, M. Diago, et al.. (1997). Multicenter Randomized, Controlled Study of Intramuscular Administration of Interferon-β for the Treatment of Chronic Hepatitis C. Journal of Interferon & Cytokine Research. 17(1). 27–30. 12 indexed citations

18.

Castro, Ángeles, et al.. (1997). Tolerance and Efficacy of Subcutaneous Interferon-β Administered for Treatment of Chronic Hepatitis C. Journal of Interferon & Cytokine Research. 17(2). 65–67. 4 indexed citations

19.

Soriano, Vincent, Javier García‐Samaniego, Ángeles Castro, et al.. (1995). Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients. Journal of Infection. 31(1). 9–13. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact